Hollsteen
← KLA

Research and development

Flow – sum over the period · $M

QuartersFiscal years

$MResearch and development · Q1 FY2016: $120M · 10-Q 0000319201-15-000060 filed Oct 22, 2015Research and development · Q2 FY2016: $118M · 10-Q 0000319201-16-000065 filed Jan 28, 2016Research and development · Q3 FY2016: $116M · 10-Q 0000319201-16-000077 filed Apr 26, 2016Research and development · Q4 FY2016: $127M · derived · 10-K 0000319201-17-000034 filed Aug 4, 2017Research and development · Q1 FY2017: $129M · 10-Q 0000319201-16-000104 filed Oct 20, 2016Research and development · Q2 FY2017: $131M · 10-Q 0000319201-17-000006 filed Jan 27, 2017Research and development · Q3 FY2017: $130M · 10-Q 0000319201-17-000017 filed Apr 28, 2017Research and development · Q4 FY2017: $137M · derived · 10-K 0000319201-18-000045 filed Aug 6, 2018Research and development · Q1 FY2018: $147M · 10-Q 0000319201-18-000055 filed Oct 31, 2018Research and development · Q2 FY2018: $157M · 10-Q 0000319201-19-000009 filed Jan 29, 2019Research and development · Q3 FY2018: $153M · 10-Q 0000319201-19-000018 filed May 8, 2019Research and development · Q4 FY2018: $152M · derived · 10-K 0000319201-19-000031 filed Aug 16, 2019Research and development · Q1 FY2019: $154M · 10-Q 0000319201-18-000055 filed Oct 31, 2018Research and development · Q2 FY2019: $166M · 10-Q 0000319201-19-000009 filed Jan 29, 2019Research and development · Q3 FY2019: $185M · 10-Q 0000319201-19-000018 filed May 8, 2019Research and development · Q4 FY2019: $207M · derived · 10-K 0000319201-20-000047 filed Aug 10, 2020Research and development · Q1 FY2020: $211M · 10-Q 0000319201-19-000039 filed Oct 31, 2019Research and development · Q2 FY2020: $221M · 10-Q 0000319201-20-000008 filed Feb 5, 2020Research and development · Q3 FY2020: $215M · 10-Q 0000319201-20-000026 filed May 6, 2020Research and development · Q4 FY2020: $217M · derived · 10-K 0000319201-21-000029 filed Aug 6, 2021Research and development · Q1 FY2021: $219M · 10-Q 0000319201-20-000057 filed Oct 30, 2020Research and development · Q2 FY2021: $229M · 10-Q 0000319201-21-000008 filed Feb 4, 2021Research and development · Q3 FY2021: $239M · 10-Q 0000319201-21-000017 filed Apr 30, 2021Research and development · Q4 FY2021: $241M · derived · 10-K 0000319201-22-000023 filed Aug 5, 2022Research and development · Q1 FY2022: $258M · 10-Q 0000319201-21-000037 filed Oct 28, 2021Research and development · Q2 FY2022: $265M · 10-Q 0000319201-22-000006 filed Jan 28, 2022Research and development · Q3 FY2022: $285M · 10-Q 0000319201-22-000012 filed Apr 29, 2022Research and development · Q4 FY2022: $297M · derived · 10-K 0000319201-23-000031 filed Aug 4, 2023Research and development · Q1 FY2023: $319M · 10-Q 0001628280-22-027311 filed Oct 28, 2022Research and development · Q2 FY2023: $333M · 10-Q 0000319201-23-000010 filed Jan 27, 2023Research and development · Q3 FY2023: $328M · 10-Q 0000319201-23-000020 filed Apr 28, 2023Research and development · Q4 FY2023: $317M · derived · 10-K 0000319201-24-000021 filed Aug 5, 2024Research and development · Q1 FY2024: $311M · 10-Q 0000319201-23-000039 filed Oct 27, 2023Research and development · Q2 FY2024: $320M · 10-Q 0000319201-24-000006 filed Jan 26, 2024Research and development · Q3 FY2024: $322M · 10-Q 0000319201-24-000012 filed Apr 26, 2024Research and development · Q4 FY2024: $326M · derived · 10-K 0000319201-25-000024 filed Aug 8, 2025Research and development · Q1 FY2025: $323M · 10-Q 0000319201-24-000027 filed Oct 31, 2024Research and development · Q2 FY2025: $346M · 10-Q 0000319201-25-000006 filed Jan 31, 2025Research and development · Q3 FY2025: $338M · 10-Q 0000319201-25-000012 filed May 1, 2025Research and development · Q4 FY2025: $353M · derived · 10-K 0000319201-26-000027 filed Aug 6, 2026Research and development · Q1 FY2026: $360M · 10-Q 0000319201-25-000034 filed Oct 31, 2025Research and development · Q2 FY2026: $384M · 10-Q 0000319201-26-000008 filed Jan 30, 2026Research and development · Q3 FY2026: $389M · 10-Q 0000319201-26-000016 filed Apr 30, 2026Research and development · Q4 FY2026: $399M · derived · 10-K 0000319201-26-000027 filed Aug 6, 2026320399a120Q1 FY2016Q4 FY2026Q2 FY2024
$MResearch and development · Q2 FY2023: $333M · 10-Q 0000319201-23-000010 filed Jan 27, 2023Research and development · Q3 FY2023: $328M · 10-Q 0000319201-23-000020 filed Apr 28, 2023Research and development · Q4 FY2023: $317M · derived · 10-K 0000319201-24-000021 filed Aug 5, 2024Research and development · Q1 FY2024: $311M · 10-Q 0000319201-23-000039 filed Oct 27, 2023Research and development · Q2 FY2024: $320M · 10-Q 0000319201-24-000006 filed Jan 26, 2024Research and development · Q3 FY2024: $322M · 10-Q 0000319201-24-000012 filed Apr 26, 2024Research and development · Q4 FY2024: $326M · derived · 10-K 0000319201-25-000024 filed Aug 8, 2025Research and development · Q1 FY2025: $323M · 10-Q 0000319201-24-000027 filed Oct 31, 2024320323333Q2 FY2023Q1 FY2025Q2 FY2024
Q2 FY2024
320$M
All values (44)
PeriodValue ($M)Status
Q4 FY2026399derived
Q3 FY2026389reported
Q2 FY2026384reported
Q1 FY2026360reported
Q4 FY2025353derived
Q3 FY2025338reported
Q2 FY2025346reported
Q1 FY2025323reported
Q4 FY2024326derived
Q3 FY2024322reported
Q2 FY2024320reported
Q1 FY2024311reported
Q4 FY2023317derived
Q3 FY2023328reported
Q2 FY2023333reported
Q1 FY2023319reported
Q4 FY2022297derived
Q3 FY2022285reported
Q2 FY2022265reported
Q1 FY2022258reported
Q4 FY2021241derived
Q3 FY2021239reported
Q2 FY2021229reported
Q1 FY2021219reported
Q4 FY2020217derived
Q3 FY2020215reported
Q2 FY2020221reported
Q1 FY2020211reported
Q4 FY2019207derived
Q3 FY2019185reported
Q2 FY2019166reported
Q1 FY2019154reported
Q4 FY2018152derived
Q3 FY2018153reported
Q2 FY2018157reported
Q1 FY2018147reported
Q4 FY2017137derived
Q3 FY2017130reported
Q2 FY2017131reported
Q1 FY2017129reported
Q4 FY2016127derived
Q3 FY2016116reported
Q2 FY2016118reported
Q1 FY2016120reported

CSV with all sources · Technical ID: rnd

More metrics for KLA

Income statement

Per share

Balance sheet

Cash flow

Debt and interest

Revenue by segment/product/region

Gross profit by segment

Sources & calculation
Value
$320M
Period
Q2 FY2024, ended Dec 31, 2023 · quarterly value (3 months, not cumulative)
Source
10-Q, filed Jan 26, 2024 · 0000319201-24-000006
Location
us-gaap:ResearchAndDevelopmentExpense
Confidence
1. – directly from an XBRL fact in the filing (or calculated exactly from it)

Versions

v1$320MJan 26, 202410-Q 0000319201-24-000006reported · confidence 1. · current